Rapamycin derivative or an IMPDH inhibitor for treating polycystic kidney disease

Details for Australian Patent Application No. 2006314453 (hide)

Owner Novartis AG

Inventors Farber, Lothar; Gschaidmeier, Harald

Agent Davies Collison Cave

Pub. Number AU-B-2006314453

PCT Pub. Number WO2007/057466

Priority 0523659.1 21.11.05 GB

Filing date 20 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 10 March 2011

International Classifications

A61K 31/436 (2006.01)

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/365 (2006.01) - Lactones

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7056 (2006.01)

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/057466 Priority application(s): WO2007/057466

10 March 2011 Application Accepted

  Published as AU-B-2006314453

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006314461-Radar system

2006314445-Catalytic process for the oligomerization of olefinic monomers